Mirae Asset Global ETFs Holdings
LXRX icon

Mirae Asset Global ETFs Holdings’s Lexicon Pharmaceuticals LXRX Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$274K Buy
+114,114
New +$222K ﹤0.01% 2330
2025
Q2 		– Sell
-68,683
Closed -$31.6K – 3143
2025
Q1 		$31.6K Buy
68,683
+2,901
+4% +$1.83K ﹤0.01% 2922
2024
Q4 		$48.6K Buy
65,782
+2,824
+4% +$3.4K ﹤0.01% 2910
2024
Q3 		$98.8K Buy
62,958
+15,775
+33% +$28.1K ﹤0.01% 2714
2024
Q2 		$79.3K Buy
+47,183
New +$84.6K ﹤0.01% 2657

Other funds holding LXRX

AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
Sessa Capital
Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Mirae Asset Global ETFs Holdings's LXRX Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings opened a new position in Lexicon Pharmaceuticals (LXRX) in Q2 2026: 114,114 shares worth $274K. The stake represents ﹤0.01% of the portfolio and ranks #2330 among its holdings. This is a return to the name: Mirae Asset Global ETFs Holdings previously reported a position in LXRX as recently as Q1 2025.

Mirae Asset Global ETFs Holdings first reported a position in LXRX in Q2 2024 and has held it in 5 quarters since. 149 funds tracked by Wall St. Rank hold LXRX as of Q2 2026.

  • Mirae Asset Global ETFs Holdings held 114,114 shares of Lexicon Pharmaceuticals worth $274K as of Q2 2026.
  • Lexicon Pharmaceuticals was a new Mirae Asset Global ETFs Holdings position in Q2 2026.
  • Lexicon Pharmaceuticals made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #2330 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Lexicon Pharmaceuticals in Q2 2024 and has held it in 5 quarters since.
  • 149 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.